Atika Capital Management LLC bought a new position in shares of Progyny, Inc. (NASDAQ:PGNY - Free Report) during the 4th quarter, according to its most recent filing with the SEC. The institutional investor bought 332,000 shares of the company's stock, valued at approximately $5,727,000. Atika Capital Management LLC owned approximately 0.39% of Progyny at the end of the most recent reporting period.
A number of other institutional investors have also added to or reduced their stakes in PGNY. Signaturefd LLC lifted its position in shares of Progyny by 1,355.0% in the 4th quarter. Signaturefd LLC now owns 1,455 shares of the company's stock worth $25,000 after purchasing an additional 1,355 shares during the period. GAMMA Investing LLC lifted its holdings in Progyny by 341.4% during the fourth quarter. GAMMA Investing LLC now owns 1,611 shares of the company's stock worth $28,000 after buying an additional 1,246 shares during the period. Nisa Investment Advisors LLC boosted its position in Progyny by 108.4% during the 4th quarter. Nisa Investment Advisors LLC now owns 2,934 shares of the company's stock valued at $51,000 after acquiring an additional 1,526 shares in the last quarter. Caitlin John LLC increased its holdings in shares of Progyny by 2,974.8% in the 4th quarter. Caitlin John LLC now owns 3,290 shares of the company's stock valued at $57,000 after acquiring an additional 3,183 shares during the period. Finally, SBI Securities Co. Ltd. bought a new position in shares of Progyny in the 4th quarter worth $74,000. Hedge funds and other institutional investors own 94.93% of the company's stock.
Wall Street Analysts Forecast Growth
A number of brokerages recently weighed in on PGNY. Canaccord Genuity Group raised their price objective on Progyny from $17.00 to $23.00 and gave the company a "hold" rating in a research report on Friday, February 28th. BTIG Research upgraded shares of Progyny from a "neutral" rating to a "buy" rating and set a $28.00 price objective for the company in a research note on Monday, March 31st. JPMorgan Chase & Co. raised their target price on shares of Progyny from $17.00 to $23.00 and gave the company a "neutral" rating in a research note on Tuesday, January 28th. Finally, Bank of America lifted their price target on shares of Progyny from $21.00 to $25.00 and gave the stock a "buy" rating in a report on Tuesday, February 11th. Eight equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus price target of $23.64.
Get Our Latest Stock Report on PGNY
Progyny Stock Down 1.6 %
Shares of NASDAQ:PGNY traded down $0.35 during trading on Friday, hitting $21.91. The stock had a trading volume of 207,478 shares, compared to its average volume of 1,722,193. The stock has a 50-day simple moving average of $22.03 and a two-hundred day simple moving average of $18.65. The stock has a market capitalization of $1.87 billion, a price-to-earnings ratio of 37.78, a price-to-earnings-growth ratio of 2.39 and a beta of 1.33. Progyny, Inc. has a 12-month low of $13.39 and a 12-month high of $35.39.
Progyny Company Profile
(
Free Report)
Progyny, Inc, a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists.
Further Reading
Before you consider Progyny, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Progyny wasn't on the list.
While Progyny currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
